Q2 2024 Holdings
Filed 2024-08-14 | 9 holdings | $859.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $246.1M | 4,575,558 | 28.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $237.1M | 3,541,095 | 27.6% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $163.9M | 2,080,946 | 19.1% |
| Geron Corp(GERN) | COM | 374163103 | $106.2M | 23,915,480 | 12.4% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $68.8M | 1,525,902 | 8.0% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $14.3M | 325,140 | 1.7% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $10.3M | 452,040 | 1.2% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $8.1M | 200,000 | 0.9% |
| Elevation Oncology Inc | COM | 28623U101 | $4.8M | 1,916,290 | 0.6% |